Over 60 million people worldwide are diagnosed with glaucomatous optic neuropathy,
which is estimated to be responsible for 8.4 million cases of irreversible blindness globally …

Papilledema, defined as swelling of the optic disc, frequently occurs in the setting of
increased ICP and in a variety of medical conditions, including pseudotumor cerebri, sinus …

Nanoscale materials have been explored extensively as agents for therapeutic and
diagnostic (ie, theranostic) applications. Research efforts have shifted from exploring new …

Many ophthalmologists and members of the lay public alike view glaucoma in its historical
context—that is, as exclusively a disease of the eye. This view has been (and remains) …

NAP (davunetide) is a novel neuroprotective compound with mechanism of action that
appears to involve microtubule (MT) stabilization and repair. To evaluate, for the first time …

Glaucoma is a neurodegenerative disease that causes progressive, irreversible vision loss.
Currently, intraocular pressure (IOP) is the only modifiable risk factor for glaucoma …

Lycium Barbarum Polysaccharides (LBP) are the active components of Wolfberry (a
traditional Chinese medicine) which has long been used for improving visual function. This …

Manganese-enhanced magnetic resonance imaging (MEMRI) rose to prominence in the
1990s as a sensitive approach to high contrast imaging. Following the discovery of …

Although elevated intraocular pressure (IOP) and age are major risk factors for glaucoma,
their effects on glaucoma pathogenesis remain unclear. This study examined the onset and …

Our previous results showed that the polysaccharides extracted from Lycium barbarum
(LBP) could delay secondary degeneration of retinal ganglion cell bodies and improve the …